Compared to chemotherapy, treatment with selumetinib not associated with improved long term survival for patients with an uncommon eye cancer
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate...